Work

miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation

Year: 2012

Type: article

Source: Leukemia

DOI: 10.1038/leu.2012.224

Authors: X Lin, K L Rice, M Buzzai, E Hexner, F F Costa, O Kilpivaara, A Mullally, M B Soares, B L Ebert, R Levine, J D Licht

Institutions: Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Novartis (Italy), Abramson Cancer Center, University of Pennsylvania, Memorial Sloan Kettering Cancer Center, Brigham and Women's Hospital, Harvard University

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: G1985082129, G5217826310, Molecular genetic analysis of tyrosine kinases in myeloproliferative disorders

OpenAlex ID: W2081331674

FWCI: 2.497

Cites: 38

Cited by: 56

Related to: 10